Summary

The omega-3 market is estimated to be USD 4.88 billion in 2026 and is projected to reach USD 8.73 billion by 2031, at a CAGR of 12.3%.

The omega-3 market is gaining significant traction, driven by the increasing recognition of the roles of EPA and DHA in cardiovascular health, cognitive function, vision, joint health, and infant brain development, as well as a growing consumer shift toward preventive healthcare and functional nutrition. The infant formula sector has witnessed explosive growth, driven by rising awareness among parents about the importance of early nutrition for cognitive and physical development, particularly the role of DHA and other essential nutrients, and regulatory mandates and recommendations in regions such as Europe, North America, and China requiring or encouraging DHA fortification in infant formula. However, high costs involved in R&D activities and unstable fish oil prices are expected to pose a challenge to the omega-3 market’s growth.

Disruptions in the omega-3 market may offer opportunities for players

The omega-3 market is undergoing fundamental shifts, opening up new opportunities for companies. One of the most significant changes is the shift toward sustainable and plant-based sources such as algal oil and fermentation-based omega-3, which eliminate fish oil supply concerns and resonate with vegan and green consumers. Regulatory updates, such as the mandatory fortification of DHA in infant nutrition and broader approvals for cardiovascular and cognitive well-being claims, are also driving steady demand in both developed and emerging markets. Meanwhile, technological advances such as microencapsulation are enhancing stability and flavor, allowing omega-3 to be incorporated in new food and beverage applications.

On the application front, Omega-3 is increasingly being used in pharmaceuticals, pet food, and aquaculture, apart from conventional supplements. Pharma-grade formulations for neurological and cardiovascular health are gaining momentum, while high-end pet food and fortified aquaculture feed are experiencing significant growth. Alongside growing demand for convenience formats of functional nutrition products (gummies, powders, RTDs) and increasing consumer spending on health supplement products in South America and the Asia Pacific, these trends are redefining the landscape of the market. Players who innovate in sourcing, product development, and sustainability have a good chance of securing growth in emerging markets.

The dietary supplement segment is projected to be one of the fastest-growing segments

The dietary supplement category is one of the major growth drivers for the omega-3 market as consumers place greater emphasis on preventive healthcare and turn to convenient solutions for heart, brain, eye, and joint well-being. Supported by regulatory approvals for health claims, supplements offer confidence and convenience, as advancements in delivery forms, such as softgels, gummies, and powders, make them attractive to people of all ages. This synergy of health consciousness, aging population, and product creativity is driving robust and consistent demand for omega-3 in dietary supplements.

The liquid form of omega-3 is expected to hold a larger share of the omega-3 market

The majority of commercial omega-3 comes from fish oil, algal oil, and krill oil, which are naturally liquid forms and commonly used in dietary supplements, infant formula, functional foods, and pharmaceuticals. Liquids can accommodate higher purity, greater bioavailability, and simpler inclusion in soft gels, emulsions, and fortified liquid food. While dry formulations (powders, microencapsulated omega-3) are increasing as a result of uses in gummies, powders, and bakery applications, the liquid form continues to hold a significant market share as it is the most cost-efficient, mass-produced, and immediately applicable state across industries.

The eicosapentaenoic acid (EPA) segment is expected to grow at a significant rate

The EPA has been shown to benefit heart health, including reducing triglyceride levels, decreasing inflammation, and improving overall cardiovascular function. As awareness of these health benefits increases among consumers, there is a growing demand for omega-3 supplements and fortified foods and beverages containing EPA, which contributes to the expansion of the omega-3 market.

The US is estimated to dominate the North American omega-3 market during the forecast period

The US is one of the largest global markets for omega-3. The consumption of omega-3-based products and supplements has increased significantly due to rising consumer awareness of their various health benefits and their availability in the US market. The omega-3 consumption pattern in the US is driven toward categories such as capsules, dietary supplements, and infant formula. However, the country has one of the largest consumer markets in the world. Recently, the EPA/DHA (omega-3) ingredients sector has experienced a surge in product innovations, introducing new omega-3 variants and expanding the utilization of plant-based sources. As consumers increasingly prioritize the health of oceans, there is a growing demand for plant-based omega-3 ingredients within the dietary supplement sector.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the omega-3 market.

- By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45%
- By Designation: CXOs – 25%, Managers – 40%, Executives – 35%
- By Region: North America – 22%, Europe – 28%, Asia Pacific – 32%, South America – 10%, and Rest of the World – 8%

Prominent companies in the market include BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK).

Research Coverage
This research report categorizes the omega-3 market by type (docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linolenic acid (ALA)), source (marine [fish, algal, krill, and other marine sources] and plant [nuts & seeds and vegetable oils]), application (dietary supplements, functional foods & beverages, pharmaceuticals, infant formulas, and pet food and feed), form (dry and liquid), manufacturing technology (qualitative) (extraction, refining & purification, concentration & conversion, encapsulation & stabilization, and fermentation & biotechnology), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of omega-3 ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the omega-3 market. This report covers the competitive analysis of upcoming startups in the omega-3 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscapes, among others.

Reasons to Buy This Report
The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall omega-3 and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:
- Analysis of key drivers (Rising adoption of algal oil and plant-based omega-3 (flaxseed, chia, canola) due to concerns over fish oil sustainability), restraints (lack of clarity among consumers about daily recommended intake and health claims), opportunities (increase in research for development of alternative sources to obtain omega-3), and challenges (highly unstable fish oil prices) influencing the growth of the omega-3 market
- Product Development/Innovation: Detailed insights on research & development activities and new product launches in the omega-3 market
- Market Development: Comprehensive information about lucrative markets—the report analyzes omega-3 across varied regions
- Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the omega-3 market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), and other players in the omega-3 market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKETS COVERED AND REGIONS CONSIDERED 30
1.3.2 INCLUSIONS AND EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 32
1.3.4 CURRENCY CONSIDERED 32
1.3.5 UNITS CONSIDERED 33
1.4 STAKEHOLDERS 33
1.5 SUMMARY OF CHANGES 34

2 EXECUTIVE SUMMARY 35
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 35
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 37
2.3 DISRUPTIVE TRENDS IN OMEGA-3 MARKET 38
2.4 HIGH-GROWTH SEGMENTS 39
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 40

3 PREMIUM INSIGHTS 41
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET 41
3.2 OMEGA-3 MARKET, BY TYPE AND REGION 42
3.3 OMEGA-3 MARKET, BY 3 TYPES 42
3.4 OMEGA-3 MARKET, BY SOURCE 43
3.5 OMEGA-3 MARKET, BY FORM 43
3.6 OMEGA-3 MARKET, BY APPLICATION 43
3.7 OMEGA-3 MARKET, BY COUNTRY 44

4 MARKET OVERVIEW 45
4.1 INTRODUCTION 45
4.2 MARKET DYNAMICS 46
4.2.1 DRIVERS 46
4.2.1.1 Growing consumer awareness regarding health benefits 46
4.2.1.2 Increasing use in food and feed products 48
4.2.1.2.1 Rising demand for mother and infant nutrition products 48
4.2.1.2.2 Mandatory inclusion of algal DHA in infant formula 48
4.2.1.2.3 Growth focus of food processing companies on fortification 48
4.2.1.2.4 Increasing applications in pet food and feed 49
4.2.1.3 Shift toward pharmaceutical-grade high-concentrate omega-3 oils in developed markets 50
4.2.1.4 Emergence of innovative production technologies 50
4.2.2 RESTRAINTS 52
4.2.2.1 Declining fish oil supply due to sustainability issues in fisheries 52
4.2.2.2 Lack of clarity on daily intake recommendations and health claims 53
4.2.3 OPPORTUNITIES 53
4.2.3.1 Increasing research on alternative sources 53
4.2.3.1.1 Rising consumer demand for plant-based products 54
4.2.3.1.2 Growing focus on microalgae-based omega-3 production 55
4.2.3.1.3 Side effects and allergies related to fish-based products 55
4.2.3.2 Favorable regulatory environment 56
4.2.3.3 Integration of microencapsulation technology 56
4.2.4 CHALLENGES 57
4.2.4.1 High costs involved in R&D activities 57
4.2.4.2 Volatility in fish oil prices 57
4.2.4.3 Instability of omega-3 oils 58
4.3 UNMET NEEDS AND WHITE SPACES 58
4.3.1 UNMET NEEDS IN THE OMEGA 3 MARKET 58
4.3.2 WHITE SPACE OPPORTUNITIES 59
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 60
4.4.1 INTERCONNECTED MARKETS 60
4.4.2 CROSS SECTOR OPPORTUNITIES 61
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 62

5 INDUSTRY TRENDS 63
5.1 PORTER’S FIVE FORCES ANALYSIS 63
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 64
5.1.2 BARGAINING POWER OF SUPPLIERS 64
5.1.3 BARGAINING POWER OF BUYERS 64
5.1.4 THREAT OF SUBSTITUTES 65
5.1.5 THREAT OF NEW ENTRANTS 65
5.2 MACROECONOMIC OUTLOOK 65
5.2.1 INTRODUCTION 65
5.3 MACROECONOMIC INDICATORS 65
5.3.1 SUSTAINABILITY AND CIRCULAR ECONOMY INITIATIVES 65
5.3.2 PREVENTIVE HEALTHCARE EXPENDITURE 66
5.3.3 GROWING GERIATRIC POPULATION 67
5.4 VALUE CHAIN ANALYSIS 68
5.4.1 RESEARCH AND PRODUCT DEVELOPMENT 68
5.4.2 SOURCING 69
5.4.3 PRODUCTION AND PROCESSING 69
5.4.4 DISTRIBUTION 69
5.4.5 MARKETING AND SALES 69
5.4.6 END USERS 69
5.5 ECOSYSTEM ANALYSIS 70
5.5.1 DEMAND SIDE 70
5.5.2 SUPPLY SIDE 70
5.6 PRICING ANALYSIS 72
5.6.1 INTRODUCTION 72
5.6.2 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE 72
5.6.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION 73
5.6.4 AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE 74
5.7 TRADE ANALYSIS 75
5.7.1 IMPORT ANALYSIS: OMEGA-3 75
5.7.2 EXPORT ANALYSIS: OMEGA-3 76
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 77
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78
5.10 INVESTMENT AND FUNDING SCENARIO 78
5.11 CASE STUDY ANALYSIS 79
5.11.1 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY 79
5.11.2 KD PHARMA GROUP: ADVANCING PHARMACEUTICAL-GRADE OMEGA-3 PURIFICATION TECHNOLOGIES 79
5.11.3 VERAMARIS: PIONEERING SUSTAINABLE OMEGA-3 SOLUTIONS IN AQUACULTURE 80
5.11.4 DSM-FIRMENICH: EXPANDING ALGAE-DERIVED DHA ACROSS LIFE-STAGE NUTRITION 80
5.11.5 AKER BIOMARINE EXPANDED EUROPEAN MARKET ACCESS THROUGH STRATEGIC DISTRIBUTION PARTNERSHIPS 81
5.12 IMPACT OF 2025 US TARIFFS - OMEGA-3 MARKET 81
5.12.1 INTRODUCTION 81
5.12.2 PRICE IMPACT ANALYSIS 82
5.12.3 IMPACT ON COUNTRIES/REGIONS 82
5.12.3.1 US 82
5.12.3.2 Europe 82
5.12.3.3 Asia Pacific 82
5.12.4 IMPACT ON END-USE INDUSTRIES 83

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 84
6.1 TECHNOLOGY ANALYSIS 84
6.1.1 KEY TECHNOLOGIES 84
6.1.1.1 Molecular distillation 84
6.1.1.2 Supercritical CO₂ extraction 85
6.1.1.3 Algae fermentation 85
6.1.2 COMPLEMENTARY TECHNOLOGIES 86
6.1.2.1 Stabilization & antioxidant technologies 86
6.1.2.2 Microencapsulation 86
6.1.3 ADJACENT TECHNOLOGIES 86
6.1.3.1 Precision fermentation 86
6.1.3.2 Synthetic biology & bioprocess engineering 87
6.1.4 TECHNOLOGY/PRODUCT ROADMAP 87
6.1.4.1 Short-Term | High-Purity Omega-3 Production & Stability Enhancement 87
6.1.4.2 Mid-Term | Sustainable EPA & DHA Manufacturing 87
6.1.4.3 Long-Term | Precision Nutrition & Next-Generation Omega-3 Innovation 87
6.2 PATENT ANALYSIS 88
6.3 FUTURE APPLICATIONS 89
6.3.1 CLINICAL NUTRITION & HEALTHY AGING: EXPANDING THE FUTURE OF OMEGA-3 APPLICATIONS 90
6.3.2 STABLE DHA-ENRICHED FUNCTIONAL FOODS: ADVANCING THE NEXT GENERATION OF OMEGA-3 NUTRITION 90
6.3.3 PLANT-BASED OMEGA-3 SUPPLEMENTATION: ENABLING THE FUTURE OF PERSONALIZED VEGAN NUTRITION 91
6.3.4 OMEGA-3 BIOMARKER-BASED PRENATAL NUTRITION: ENABLING PRECISION MATERNAL HEALTHCARE 91
6.4 IMPACT OF GENERATIVE AI ON OMEGA 3 MARKET 92
6.4.1 INTRODUCTION 92
6.4.2 TOP USE CASES AND MARKET POTENTIAL 92
6.4.3 BEST PRACTICES IN OMEGA 3 INDUSTRY 93
6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN OMEGA 3 MARKET 93
6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 94
6.4.6 CLIENTS’ READINESS TO ADOPT GENERATIVE AI FOR OMEGA 3 PRODUCTION 94
6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 95

7 SUSTAINABILITY AND REGULATORY LANDSCAPE 96
7.1 REGIONAL REGULATIONS AND COMPLIANCE 96
7.1.1 INDUSTRY STANDARDS 99
7.1.2 LABELING REQUIREMENTS AND CLAIMS 100
7.1.3 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS 101
7.1.3.1 Enhanced Traceability and Sustainability Requirements 101
7.1.3.2 Global Harmonization of Omega-3 Labeling and Health Claims 101
7.1.3.3 Stricter Quality, Purity, and Contaminant Standards 101
7.1.3.4 Digital Traceability, AI-Enabled Quality Monitoring, and Compliance Automation 101
7.1.3.5 Stronger Sustainability and ESG Compliance Requirements 101
7.2 SUSTAINABILITY INITIATIVES 101
7.2.1 SUSTAINABLE SOURCING 102
7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 102
7.2.3 CIRCULAR ECONOMY APPROACHES 103
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 103
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 103

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 105
8.1 DECISION-MAKING PROCESS 105
8.2 KEY STAKEHOLDERS AND BUYING CRITERIA 107
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 107
8.2.2 BUYING CRITERIA 108
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 109
8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 110
8.5 MARKET PROFITABILITY 111
8.6 REVENUE POTENTIAL 112
8.6.1 COST DYNAMICS 112

9 OMEGA-3 MARKET, BY TYPE 114
9.1 INTRODUCTION 115
9.2 DOCOSAHEXAENOIC ACID 116
9.2.1 NEED FOR PROTECTION AGAINST ALZHEIMER'S DISEASE TO DRIVE DEMAND 116
9.3 EICOSAPENTAENOIC ACID 118
9.3.1 ABILITY TO REDUCE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND 118
9.4 ALPHA-LINOLENIC ACID 119
9.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND 119

10 OMEGA-3 MARKET, BY SOURCE 121
10.1 INTRODUCTION 122
10.2 MARINE 123
10.2.1 NEED FOR HEALTHY FETAL DEVELOPMENT IN PREGNANT WOMEN TO DRIVE MARKET 123
10.2.2 FISH 126
10.2.2.1 Anchovy 127
10.2.2.2 Sardine 127
10.2.2.3 Mackerel 127
10.2.2.4 Other fish types 127
10.2.3 ALGAE 128
10.2.3.1 Schizochytrium sp. 128
10.2.3.2 Crypthecodinium cohnii 129
10.2.3.3 Nannochloropsis sp. 129
10.2.3.4 Other algae types 129
10.2.4 KRILL 129
10.2.5 OTHER MARINE SOURCES 130
10.3 PLANT 131
10.3.1 GROWING USE OF FLAX SEEDS FOR CANCER PREVENTION TO BOOST DEMAND 131
10.3.2 NUTS & SEEDS 133
10.3.3 VEGETABLE OILS 134

11 OMEGA-3 MARKET, BY APPLICATION 136
11.1 INTRODUCTION 137
11.2 DIETARY SUPPLEMENTS 138
11.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIETS TO DRIVE DEMAND 138
11.3 FUNCTIONAL FOODS & BEVERAGES 139
11.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND 139
11.3.2 DAIRY & DAIRY ALTERNATIVES 140
11.3.3 BAKERY & CEREAL PRODUCTS 141
11.3.4 CONFECTIONERY PRODUCTS 141
11.3.5 MEAT & MEAT PRODUCTS 141
11.3.6 BEVERAGES 141
11.3.7 OTHER FUNCTIONAL FOOD PRODUCTS 142
11.4 PHARMACEUTICALS 142
11.4.1 GROWING NEED TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET 142
11.5 INFANT FORMULAS 143
11.5.1 RISING CONSUMPTION OF OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND 143
11.6 PET FOOD & FEED 144
11.6.1 GREATER EMPHASIS ON ENHANCING IMMUNITY IN PETS TO DRIVE MARKET 144
11.6.2 PET FOOD 145
11.6.3 ANIMAL FEED 145

12 OMEGA-3 MARKET, BY FORM 146
12.1 INTRODUCTION 147
12.2 DRY 148
12.2.1 ENCAPSULATED STABILITY MEETS VERSATILE APPLICATIONS 148
12.3 LIQUID 149
12.3.1 HIGH BIOAVAILABILITY AND EFFICACY TO FUEL DEMAND 149

13 OMEGA 3 MARKET, BY MANUFACTURING TECHNOLOGY 151
13.1 INTRODUCTION 151
13.2 EXTRACTION 151
13.3 REFINING & PURIFICATION 151
13.4 CONCENTRATION & CONVERSION 152
13.5 ENCAPSULATION & STABILIZATION 152
13.6 FERMENTATION & BIOTECHNOLOGY 152

14 OMEGA-3 MARKET, BY REGION 154
14.1 INTRODUCTION 155
14.2 NORTH AMERICA 158
14.2.1 US 163
14.2.1.1 Growing incorporation of omega-3 in dietary supplements to drive market 163
14.2.2 CANADA 164
14.2.2.1 Increasing application in functional foods & beverages to boost market 164
14.2.3 MEXICO 166
14.2.3.1 Growing focus on heart disease prevention to drive market 166
14.3 EUROPE 168
14.3.1 GERMANY 172
14.3.1.1 Low fish consumption to boost demand for omega-3-based supplements 172
14.3.2 UK 173
14.3.2.1 Rising gastrointestinal health awareness supporting Omega-3 demand 173
14.3.3 FRANCE 175
14.3.3.1 Rising cardiovascular disease burden driving Omega-3 consumption 175
14.3.4 NORWAY 177
14.3.4.1 Production of genetically modified canola to offer lucrative growth opportunities to market players 177
14.3.5 ITALY 178
14.3.5.1 High production of dietary supplements, functional food products, and beverages to boost market 178
14.3.6 SPAIN 179
14.3.6.1 Rising consumer awareness and dietary gaps to drive market 179
14.3.7 NETHERLANDS 181
14.3.7.1 Growing incidences of depression, autism, and ADHD to drive market 181
14.3.8 REST OF EUROPE 182
14.4 ASIA PACIFIC 184
14.4.1 CHINA 189
14.4.1.1 Increasing focus on product innovations and diversification to drive market 189
14.4.2 INDIA 191
14.4.2.1 Growing incidences of heart failure to drive market 191
14.4.3 JAPAN 192
14.4.3.1 Rapidly aging population driving demand for Omega-3 supplements 192
14.4.4 AUSTRALIA & NEW ZEALAND 194
14.4.4.1 Government-led initiatives to increase awareness regarding omega-3 to drive market 194
14.4.5 REST OF ASIA PACIFIC 196
14.5 SOUTH AMERICA 197
14.5.1 BRAZIL 201
14.5.1.1 Rising demand for algal oils to drive market 201
14.5.2 ARGENTINA 203
14.5.2.1 Commercialization of omega-3 products to fuel market 203
14.5.3 REST OF SOUTH AMERICA 204
14.6 REST OF THE WORLD (ROW) 205
14.6.1 AFRICA 209
14.6.1.1 Prevalence of undernutrition among pregnant women and children to drive market 209
14.6.2 MIDDLE EAST 210
14.6.2.1 Ongoing innovations in omega-3 products to drive market 210

15 COMPETITIVE LANDSCAPE 212
15.1 OVERVIEW 212
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 212
15.3 REVENUE ANALYSIS 214
15.4 MARKET SHARE ANALYSIS 215
15.5 COMPANY VALUATION AND FINANCIAL METRICS 218
15.6 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON 219
15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 220
15.7.1 STARS 221
15.7.2 EMERGING LEADERS 221
15.7.3 PERVASIVE PLAYERS 221
15.7.4 PARTICIPANTS 221
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS 223
15.7.5.1 Company footprint 223
15.7.5.2 Regional footprint 223
15.7.5.3 Source footprint 224
15.7.5.4 Type footprint 225
15.7.5.5 Application footprint 225
15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 226
15.8.1 PROGRESSIVE COMPANIES 226
15.8.2 RESPONSIVE COMPANIES 226
15.8.3 DYNAMIC COMPANIES 226
15.8.4 STARTING BLOCKS 227
15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 228
15.9 COMPETITIVE SCENARIO AND TRENDS 230
15.9.1 OMEGA-3 MARKET: PRODUCT LAUNCHES 230
15.9.2 DEALS 231
15.9.3 EXPANSIONS 233

16 COMPANY PROFILES 234
16.1 KEY PLAYERS 234
16.1.1 DSM-FIRMENICH 234
16.1.1.1 Business overview 234
16.1.1.2 Products/Solutions/Services offered 235
16.1.1.3 Recent developments 236
16.1.1.3.1 Product launches and enhancements 236
16.1.1.4 MnM view 236
16.1.1.4.1 Key strengths 236
16.1.1.4.2 Strategic choices 236
16.1.1.4.3 Weaknesses and competitive threats 237
16.1.2 CARGILL, INCORPORATED 238
16.1.2.1 Business overview 238
16.1.2.2 Products/Solutions/Services offered 239
16.1.2.3 Recent developments 240
16.1.2.3.1 Deals 240
16.1.2.4 MnM view 240
16.1.2.4.1 Key strengths 240
16.1.2.4.2 Strategic choices 240
16.1.2.4.3 Weaknesses and competitive threats 240
16.1.3 BASF SE 241
16.1.3.1 Business overview 241
16.1.3.2 Products/Solutions/Services offered 242
16.1.3.3 Recent developments 243
16.1.3.3.1 Deals 243
16.1.3.4 MnM view 243
16.1.3.4.1 Key strengths 243
16.1.3.4.2 Strategic choices 243
16.1.3.4.3 Weaknesses and competitive threats 243
16.1.4 ADM 244
16.1.4.1 Business overview 244
16.1.4.2 Products/Solutions/Services offered 245
16.1.4.3 MnM view 246
16.1.4.3.1 Key strengths 246
16.1.4.3.2 Strategic choices 246
16.1.4.3.3 Weaknesses and competitive threats 246
16.1.5 KERRY GROUP PLC 247
16.1.5.1 Business overview 247
16.1.5.2 Products/Solutions/Services offered 248
16.1.5.3 Recent developments 249
16.1.5.3.1 Deals 249
16.1.5.4 MnM view 249
16.1.5.4.1 Key strengths 249
16.1.5.4.2 Strategic choices 249
16.1.5.4.3 Weaknesses and competitive threats 250
16.1.6 CORBION 251
16.1.6.1 Business overview 251
16.1.6.2 Products/Solutions/Services offered 252
16.1.6.3 Recent developments 253
16.1.6.3.1 Product launches and enhancements 253
16.1.6.3.2 Other developments 253
16.1.6.4 MnM view 253
16.1.7 KD PHARMA GROUP SA 254
16.1.7.1 Business overview 254
16.1.7.2 Products/Solutions/Services offered 255
16.1.7.3 Recent developments 257
16.1.7.3.1 Deals 257
16.1.7.3.2 Expansions 257
16.1.7.4 MnM view 258
16.1.8 AKER BIOMARINE 259
16.1.8.1 Business overview 259
16.1.8.2 Products/Solutions/Services offered 260
16.1.8.3 Recent developments 261
16.1.8.3.1 Product launches and enhancements 261
16.1.8.3.2 Expansions 262
16.1.8.3.3 Deals 262
16.1.8.3.4 Other developments 265
16.1.8.4 MnM view 265
16.1.9 CRODA INTERNATIONAL PLC 266
16.1.9.1 Business overview 266
16.1.9.2 Products/Solutions/Services offered 267
16.1.9.3 MnM view 268
16.1.10 EVONIK INDUSTRIES AG 269
16.1.10.1 Business overview 269
16.1.10.2 Products/Solutions/Services offered 270
16.1.10.3 Recent developments 271
16.1.10.3.1 Deals 271
16.1.10.4 MnM view 272
16.1.11 PELAGIA 273
16.1.11.1 Business overview 273
16.1.11.2 Products/Solutions/Services offered 274
16.1.11.3 Recent developments 275
16.1.11.3.1 Product launches and enhancements 275
16.1.11.3.2 Other developments 275
16.1.11.4 MnM view 276
16.1.12 GC RIEBER 277
16.1.12.1 Business overview 277
16.1.12.2 Products/Solutions/Services offered 278
16.1.12.3 Recent developments 279
16.1.12.3.1 Product launches and enhancements 279
16.1.12.3.2 Expansions 279
16.1.12.4 MnM view 280
16.1.13 COOKE AQUACULTURE INC. 281
16.1.13.1 Business overview 281
16.1.13.2 Products/Solutions/Services offered 281
16.1.13.3 Recent developments 283
16.1.13.3.1 Deals 283
16.1.13.4 MnM view 283
16.1.14 ALGISYS BIOSCIENCES, INC. 284
16.1.14.1 Business overview 284
16.1.14.2 Products/Solutions/Services offered 284
16.1.14.3 Recent developments 285
16.1.14.3.1 Other developments 285
16.1.14.4 MnM view 285
16.1.15 POLARIS 286
16.1.15.1 Business overview 286
16.1.15.2 Products/Solutions/Services offered 286
16.1.15.3 Recent developments 287
16.1.15.3.1 Product launches and enhancements 287
16.1.15.3.2 Other developments 287
16.1.15.4 MnM view 287
16.2 OTHER PLAYERS 288
16.2.1 BTSA 288
16.2.1.1 Business overview 288
16.2.1.2 Products/Solutions/Services offered 288
16.2.1.3 MnM view 289
16.2.2 NOVOSANA EUROPE B.V. 290
16.2.2.1 Business overview 290
16.2.2.2 Products/Solutions/Services offered 290
16.2.2.3 MnM view 291
16.2.3 GOLDEN OMEGA 292
16.2.3.1 Business overview 292
16.2.3.2 Products/Solutions/Services offered 292
16.2.3.3 Recent developments 293
16.2.3.3.1 Deals 293
16.2.3.4 MnM view 293
16.2.4 KINOMEGA BIOPHARM INC. 294
16.2.4.1 Business overview 294
16.2.4.2 Products/Solutions/Services offered 294
16.2.4.3 MnM view 295
16.2.5 RIMFROST AS 296
16.2.5.1 Business overview 296
16.2.5.2 Products/Solutions/Services offered 296
16.2.5.3 Recent developments 297
16.2.5.3.1 Deals 297
16.2.5.4 MnM view 297
16.2.6 ALGARITHM 298
16.2.7 SOLUTEX 298
16.2.8 CELLANA INC. 299
16.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD. 299
16.2.10 ALGAECYTES LIMITED 300

17 RESEARCH METHODOLOGY 301
17.1 RESEARCH DATA 301
17.1.1 SECONDARY DATA 301
17.1.1.1 Key data from secondary sources 302
17.1.2 PRIMARY DATA 302
17.1.2.1 Key data from primary sources 303
17.1.2.2 Breakdown of primary profiles 303
17.1.2.3 Key insights from industry experts 304
17.2 MARKET SIZE ESTIMATION 304
17.2.1 TOP-DOWN APPROACH 305
17.2.2 SUPPLY-SIDE ANALYSIS 306
17.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 306
17.3 DATA TRIANGULATION AND MARKET BREAKUP 308
17.4 RESEARCH ASSUMPTIONS 309
17.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 310

18 ADJACENT & RELATED MARKETS 311
18.1 INTRODUCTION 311
18.2 STUDY LIMITATIONS 311
18.3 FUNCTIONAL FOOD INGREDIENTS MARKET 311
18.3.1 MARKET DEFINITION 311
18.3.2 MARKET OVERVIEW 312
18.4 MARINE COLLAGEN MARKET 313
18.4.1 MARKET DEFINITION 313
18.4.2 MARKET OVERVIEW 313

19 APPENDIX 315
19.1 DISCUSSION GUIDE 315
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 322
19.3 CUSTOMIZATION OPTIONS 324
19.4 RELATED REPORTS 324
19.5 AUTHOR DETAILS 325

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 OMEGA-3 MARKETS COVERED 30.
FIGURE 2 STUDY YEARS CONSIDERED 32.
FIGURE 3 MARKET SCENARIO 35.
FIGURE 4 OMEGA-3 MARKET, 2022–2031 36.
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET,.
JULY 2021–MAY 2026 37.
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF OMEGA-3 MARKET 38.
FIGURE 7 OMEGA-3 MARKET: HIGH-GROWTH SEGMENTS, 2026–2031 39.
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 40.
FIGURE 9 INCREASING DEMAND FOR OMEGA-3 ACROSS FUNCTIONAL FOODS AND DIETARY SUPPLEMENTS TO SUPPORT MARKET GROWTH 41.
FIGURE 10 TYPE SEGMENT DOCOSAHEXAENOIC ACID (DHA) AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026 42.
FIGURE 11 OMEGA-3 DOCOSAHEXAENOIC ACID (DHA) TYPE SEGMENT TO LEAD MARKET.
IN 2026 42.
FIGURE 12 MARINE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 43.
FIGURE 13 BY FORM SEGMENT DRY FORM SEGMENT TO DOMINATE MARKET IN 2026 43.
FIGURE 14 DIETARY SUPPLEMENTS APPLICATION SEGMENT TO DOMINATE MARKET IN 2026 43.
FIGURE 15 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 44.
FIGURE 16 OMEGA-3 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46.
FIGURE 17 RECOMMENDED EPA LEVELS IN DOG FOOD (MG) 50.
FIGURE 18 MICROALGAE PROCESSING FOR OMEGA-3 55.
FIGURE 19 OMEGA-3 MARKET: PORTER’S FIVE FORCES ANALYSIS 63.
FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP,.
BY COUNTRY, 2023 66.
FIGURE 21 GLOBAL POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION),.
2014–2025 67.
FIGURE 22 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS 68.
FIGURE 23 OMEGA-3 MARKET ECOSYSTEM MAP 71.
FIGURE 24 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE, 2025 (USD) 73.
FIGURE 25 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 74.
FIGURE 26 IMPORT OF HS CODE 1504, BY KEY COUNTRY, 2022–2025 (USD) 75.
FIGURE 27 EXPORT OF HS CODE 1504, BY KEY COUNTRY, 2022–2025 (USD) 76.
FIGURE 28 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES 78.
FIGURE 29 INVESTMENT AND FUNDING SCENARIO 78.
FIGURE 30 NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026 88.
FIGURE 31 FUTURE APPLICATIONS 89.
FIGURE 32 OMEGA-3 MARKET DECISION-MAKING FACTORS 106.
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 107.
FIGURE 34 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 108.
FIGURE 35 ADOPTION BARRIERS AND INTERNAL CHALLENGES 109.
FIGURE 36 OMEGA-3 MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 115.
FIGURE 37 OMEGA-3 MARKET, BY SOURCE, 2026 VS. 2031 (USD MILLION) 122.
FIGURE 38 OMEGA-3 MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION) 137.
FIGURE 39 OMEGA-3 MARKET, BY FORM, 2026 VS. 2031 (USD MILLION) 147.
FIGURE 40 INDIA TO RECORD HIGHEST GROWTH RATE IN THE OMEGA-3 MARKET 156.
FIGURE 41 NORTH AMERICA: REGIONAL SNAPSHOT 159.
FIGURE 42 ASIA PACIFIC: REGIONAL SNAPSHOT 185.
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS, 2023–2025 (USD BILLION) 215.
FIGURE 44 OMEGA-3 MARKET SHARE ANALYSIS, 2025 216.
FIGURE 45 COMPANY VALUATION FOR MAJOR PLAYERS IN OMEGA-3 MARKET 218.
FIGURE 46 EV/EBITDA OF MAJOR PLAYERS 218.
FIGURE 47 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON 219.
FIGURE 48 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 222.
FIGURE 49 OMEGA-3 MARKET: COMPANY FOOTPRINT, 2024 223.
FIGURE 50 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 227.
FIGURE 51 DSM-FIRMENICH: COMPANY SNAPSHOT 235.
FIGURE 52 CARGILL, INCORPORATED: COMPANY SNAPSHOT 239.
FIGURE 53 BASF SE: COMPANY SNAPSHOT 242.
FIGURE 54 ADM: COMPANY SNAPSHOT 245.
FIGURE 55 KERRY GROUP PLC: COMPANY SNAPSHOT 248.
FIGURE 56 CORBION: COMPANY SNAPSHOT 252.
FIGURE 57 KD PHARMA GROUP SA: COMPANY SNAPSHOT 255.
FIGURE 58 AKER BIOMARINE: COMPANY SNAPSHOT 260.
FIGURE 59 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT 267.
FIGURE 60 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT 270.
FIGURE 61 PELAGIA: COMPANY SNAPSHOT 274.
FIGURE 62 GC RIEBER: COMPANY SNAPSHOT 278.
FIGURE 63 OMEGA-3 MARKET: RESEARCH DESIGN 301.
FIGURE 64 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION,.
AND REGION 303.
FIGURE 65 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 305.
FIGURE 66 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 306.
FIGURE 67 OMEGA-3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 307.
FIGURE 68 DATA TRIANGULATION 308.
TABLE 1 INCLUSIONS AND EXCLUSIONS 31.
TABLE 2 USD EXCHANGE RATES, 2021–2025 33.
TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION 47.
TABLE 4 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS 54.
TABLE 5 KEY MOVES AND STRATEGIC FOCUS 62.
TABLE 6 OMEGA-3 MARKET: PORTER’S FIVE FORCES ANALYSIS 64.
TABLE 7 OMEGA-3 MARKET: SUPPLY CHAIN (ECOSYSTEM) 71.
TABLE 8 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TON) 73.
TABLE 9 AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE, 2022–2025 (USD/TON) 74.
TABLE 10 TOP IMPORTERS OF OMEGA-3, 2022–2025 (USD) 76.
TABLE 11 TOP EXPORTERS OF OMEGA-3, 2022–2025 (USD) 77.
TABLE 12 OMEGA-3 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 77.
TABLE 13 PATENTS PERTAINING TO OMEGA 3 MARKET, 2021–2026 88.
TABLE 14 TOP USE CASES AND MARKET POTENTIAL 92.
TABLE 15 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 93.
TABLE 16 OMEGA 3 MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 93.
TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 94.
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96.
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96.
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97.
TABLE 21 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97.
TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98.
TABLE 23 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98.
TABLE 24 INDUSTRY STANDARDS IN OMEGA-3 MARKET 99.
TABLE 25 LABELING REQUIREMENTS AND CLAIMS IN OMEGA-3 MARKET 100.
TABLE 26 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN OMEGA-3 MARKET 104.
TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES 108.
TABLE 28 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES 108.
TABLE 29 UNMET NEEDS IN OMEGA MARKET, BY APPLICATION INDUSTRIES ACROSS THE SUPPLY CHAIN 110.
TABLE 30 COST DYNAMICS IN OMEGA 3 MARKET 112.
TABLE 31 OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 116.
TABLE 32 OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 116.
TABLE 33 FOOD SOURCES FOR DHA (GRAMS PER SERVING) 117.
TABLE 34 DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION) 117.
TABLE 35 DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION) 118.
TABLE 36 FOOD SOURCES FOR EPA (GRAMS PER SERVING) 118.
TABLE 37 EICOSAPENTAENOIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION) 119.
TABLE 38 EICOSAPENTAENOIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION) 119.
TABLE 39 FOOD SOURCES FOR ALA (GRAMS PER SERVING) 120.
TABLE 40 ALPHA-LINOLENIC ACID MARKET, BY REGION, 2022–2025 (USD MILLION) 120.
TABLE 41 ALPHA-LINOLENIC ACID MARKET, BY REGION, 2026–2031 (USD MILLION) 120.
TABLE 42 OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 122.
TABLE 43 OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 122.
TABLE 44 OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 123.
TABLE 45 OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 123.
TABLE 46 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS 124.
TABLE 47 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION,.
2022–2025 (USD MILLION) 124.
TABLE 48 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION,.
2026–2031 (USD MILLION) 125.
TABLE 49 OMEGA-3 MARKET FROM MARINE SOURCE, BY REGION, 2022–2025 (KILOTONS) 125.
TABLE 50 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2026–2031 (KILOTONS) 125.
TABLE 51 OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE,.
2022–2025 (USD MILLION) 126.
TABLE 52 OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE,.
2026–2031 (USD MILLION) 126.
TABLE 53 OMEGA-3 MARKET FROM FISH, BY REGION, 2022–2025 (USD MILLION) 126.
TABLE 54 OMEGA-3 MARKET FROM FISH, BY REGION, 2026–2031 (USD MILLION) 127.
TABLE 55 OMEGA-3 MARKET FROM ALGAE, BY REGION, 2022–2025 (USD MILLION) 128.
TABLE 56 OMEGA-3 MARKET FROM ALGAE, BY REGION, 2026–2031 (USD MILLION) 128.
TABLE 57 OMEGA-3 MARKET FROM KRILL, BY REGION, 2022–2025 (USD MILLION) 130.
TABLE 58 OMEGA-3 MARKET FROM KRILL, BY REGION, 2026–2031 (USD MILLION) 130.
TABLE 59 OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION,.
2022–2025 (USD MILLION) 131.
TABLE 60 OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION,.
2026–2031 (USD MILLION) 131.
TABLE 61 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION,.
2022–2025 (USD MILLION) 132.
TABLE 62 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION,.
2026–2031 (USD MILLION) 132.
TABLE 63 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2022–2025 (KILOTONS) 132.
TABLE 64 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2026–2031 (KILOTONS) 133.
TABLE 65 OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE,.
2022–2025 (USD MILLION) 133.
TABLE 66 OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE,.
2026–2031 (USD MILLION) 133.
TABLE 67 OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2022–2025 (USD MILLION) 134.
TABLE 68 OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2026–2031 (USD MILLION) 134.
TABLE 69 OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2022–2025 (USD MILLION) 135.
TABLE 70 OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2026–2031 (USD MILLION) 135.
TABLE 71 OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 137.
TABLE 72 OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 138.
TABLE 73 OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION,.
2022–2025 (USD MILLION) 139.
TABLE 74 OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION,.
2026–2031 (USD MILLION) 139.
TABLE 75 OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION,.
2022–2025 (USD MILLION) 140.
TABLE 76 OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION,.
2026–2031 (USD MILLION) 140.
TABLE 77 OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION,.
2022–2025 (USD MILLION) 142.
TABLE 78 OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION,.
2026–2031 (USD MILLION) 143.
TABLE 79 OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2022–2025 (USD MILLION) 143.
TABLE 80 OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2026–2031 (USD MILLION) 144.
TABLE 81 OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2022–2025 (USD MILLION) 144.
TABLE 82 OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2026–2031 (USD MILLION) 145.
TABLE 83 OMEGA-3 MARKET, BY FORM, 2022–2025 (USD MILLION) 147.
TABLE 84 OMEGA-3 MARKET, BY FORM, 2026–2031 (USD MILLION) 147.
TABLE 85 DRY OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 148.
TABLE 86 DRY OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 148.
TABLE 87 LIQUID OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 149.
TABLE 88 LIQUID OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 150.
TABLE 89 OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 156.
TABLE 90 OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 157.
TABLE 91 OMEGA-3 MARKET, BY REGION, 2022–2025 (KILOTONS) 157.
TABLE 92 OMEGA-3 MARKET, BY REGION, 2026–2031 (KILOTONS) 157.
TABLE 93 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 159.
TABLE 94 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 159.
TABLE 95 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 160.
TABLE 96 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 160.
TABLE 97 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 160.
TABLE 98 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 160.
TABLE 99 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 161.
TABLE 100 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 161.
TABLE 101 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 161.
TABLE 102 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 161.
TABLE 103 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,.
2022–2025 (USD MILLION) 162.
TABLE 104 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,.
2026–2031 (USD MILLION) 162.
TABLE 105 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,.
2022–2025 (USD MILLION) 162.
TABLE 106 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,.
2026–2031 (USD MILLION) 162.
TABLE 107 US: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 163.
TABLE 108 US: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 163.
TABLE 109 US: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 164.
TABLE 110 US: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 164.
TABLE 111 CANADA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 165.
TABLE 112 CANADA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 165.
TABLE 113 CANADA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 165.
TABLE 114 CANADA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 165.
TABLE 115 MEXICO: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 166.
TABLE 116 MEXICO: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 167.
TABLE 117 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 167.
TABLE 118 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 167.
TABLE 119 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 168.
TABLE 120 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 169.
TABLE 121 EUROPE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 169.
TABLE 122 EUROPE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 169.
TABLE 123 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 170.
TABLE 124 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 170.
TABLE 125 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 170.
TABLE 126 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 170.
TABLE 127 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 171.
TABLE 128 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 171.
TABLE 129 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,.
2022–2025 (USD MILLION) 171.
TABLE 130 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,.
2026–2031 (USD MILLION) 171.
TABLE 131 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 172.
TABLE 132 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 172.
TABLE 133 GERMANY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 172.
TABLE 134 GERMANY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 173.
TABLE 135 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 173.
TABLE 136 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 173.
TABLE 137 UK: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 174.
TABLE 138 UK: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 174.
TABLE 139 UK: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 174.
TABLE 140 UK: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 175.
TABLE 141 FRANCE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 176.
TABLE 142 FRANCE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 176.
TABLE 143 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 176.
TABLE 144 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 176.
TABLE 145 NORWAY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 177.
TABLE 146 NORWAY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 177.
TABLE 147 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 177.
TABLE 148 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 178.
TABLE 149 ITALY: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 178.
TABLE 150 ITALY: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 179.
TABLE 151 ITALY: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 179.
TABLE 152 ITALY: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 179.
TABLE 153 SPAIN: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 180.
TABLE 154 SPAIN: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 180.
TABLE 155 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 180.
TABLE 156 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 181.
TABLE 157 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 181.
TABLE 158 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 182.
TABLE 159 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 182.
TABLE 160 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 182.
TABLE 161 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 183.
TABLE 162 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 183.
TABLE 163 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 183.
TABLE 164 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 183.
TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 185.
TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 186.
TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 186.
TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 186.
TABLE 169 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 187.
TABLE 170 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 187.
TABLE 171 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 187.
TABLE 172 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 187.
TABLE 173 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 188.
TABLE 174 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 188.
TABLE 175 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,.
2022–2025 (USD MILLION) 188.
TABLE 176 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,.
2026–2031 (USD MILLION) 188.
TABLE 177 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,.
2022–2025 (USD MILLION) 189.
TABLE 178 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,.
2026–2031 (USD MILLION) 189.
TABLE 179 CHINA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 190.
TABLE 180 CHINA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 190.
TABLE 181 CHINA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 190.
TABLE 182 CHINA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 190.
TABLE 183 INDIA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 191.
TABLE 184 INDIA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 191.
TABLE 185 INDIA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 192.
TABLE 186 INDIA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 192.
TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 193.
TABLE 188 JAPAN: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 193.
TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 193.
TABLE 190 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 193.
TABLE 191 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE,.
2022–2025 (USD MILLION) 195.
TABLE 192 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE,.
2026–2031 (USD MILLION) 195.
TABLE 193 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE,.
2022–2025 (USD MILLION) 195.
TABLE 194 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE,.
2026–2031 (USD MILLION) 195.
TABLE 195 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 196.
TABLE 196 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 196.
TABLE 197 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE,.
2022–2025 (USD MILLION) 197.
TABLE 198 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE,.
2026–2031 (USD MILLION) 197.
TABLE 199 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 198.
TABLE 200 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 198.
TABLE 201 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 198.
TABLE 202 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 198.
TABLE 203 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 199.
TABLE 204 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 199.
TABLE 205 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 199.
TABLE 206 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 199.
TABLE 207 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 200.
TABLE 208 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 200.
TABLE 209 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,.
2022–2025 (USD MILLION) 200.
TABLE 210 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,.
2026–2031 (USD MILLION) 200.
TABLE 211 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,.
2022–2025 (USD MILLION) 201.
TABLE 212 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,.
2026–2031 (USD MILLION) 201.
TABLE 213 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 202.
TABLE 214 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 202.
TABLE 215 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 202.
TABLE 216 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 202.
TABLE 217 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 203.
TABLE 218 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 203.
TABLE 219 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 203.
TABLE 220 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 204.
TABLE 221 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE,.
2022–2025 (USD MILLION) 204.
TABLE 222 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE,.
2026–2031 (USD MILLION) 204.
TABLE 223 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE,.
2022–2025 (USD MILLION) 204.
TABLE 224 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE,.
2026–2031 (USD MILLION) 205.
TABLE 225 ROW: OMEGA-3 MARKET, BY REGION, 2022–2025 (USD MILLION) 205.
TABLE 226 ROW: OMEGA-3 MARKET, BY REGION, 2026–2031 (USD MILLION) 205.
TABLE 227 ROW: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 206.
TABLE 228 ROW: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 206.
TABLE 229 ROW: OMEGA-3 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 206.
TABLE 230 ROW: OMEGA-3 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 207.
TABLE 231 ROW: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 207.
TABLE 232 ROW: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 207.
TABLE 233 ROW: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (KILOTONS) 207.
TABLE 234 ROW: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (KILOTONS) 208.
TABLE 235 ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 208.
TABLE 236 ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 208.
TABLE 237 ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022–2025 (USD MILLION) 208.
TABLE 238 ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026–2031 (USD MILLION) 209.
TABLE 239 AFRICA: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 209.
TABLE 240 AFRICA: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 210.
TABLE 241 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 210.
TABLE 242 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 210.
TABLE 243 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2022–2025 (USD MILLION) 211.
TABLE 244 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2026–2031 (USD MILLION) 211.
TABLE 245 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 211.
TABLE 246 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 211.
TABLE 247 OVERVIEW OF STRATEGIES ADOPTED BY KEY OMEGA-3 MARKET PLAYERS 213.
TABLE 248 OMEGA-3 MARKET: MARKET SHARE ANALYSIS, 2025 216.
TABLE 249 OMEGA-3 MARKET: REGIONAL FOOTPRINT, 2024 223.
TABLE 250 OMEGA-3 MARKET: SOURCE FOOTPRINT, 2024 224.
TABLE 251 OMEGA-3 MARKET: TYPE FOOTPRINT, 2024 225.
TABLE 252 OMEGA-3 MARKET: APPLICATION FOOTPRINT, 2024 225.
TABLE 253 OMEGA-3 MARKET: DETAILED LIST OF KEY STARTUPS/SMES 228.
TABLE 254 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 229.
TABLE 255 OMEGA-3 MARKET: PRODUCT LAUNCHES, JUNE 2022–JULY 2026 230.
TABLE 256 OMEGA-3 MARKET: DEALS, DECEMBER 2022–JULY 2026 231.
TABLE 257 OMEGA-3 MARKET: EXPANSIONS, FEBRUARY 2020–JULY 2026 233.
TABLE 258 DSM-FIRMENICH: COMPANY OVERVIEW 234.
TABLE 259 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 235.
TABLE 260 DSM-FIRMENICH: PRODUCT LAUNCHES AND ENHANCEMENTS 236.
TABLE 261 CARGILL, INCORPORATED: COMPANY OVERVIEW 238.
TABLE 262 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 239.
TABLE 263 CARGILL, INCORPORATED: DEALS 240.
TABLE 264 BASF SE: COMPANY OVERVIEW 241.
TABLE 265 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 242.
TABLE 266 BASF SE: DEALS 243.
TABLE 267 ADM: COMPANY OVERVIEW 244.
TABLE 268 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 245.
TABLE 269 KERRY GROUP PLC: COMPANY OVERVIEW 247.
TABLE 270 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248.
TABLE 271 KERRY GROUP PLC: DEALS 249.
TABLE 272 CORBION: COMPANY OVERVIEW 251.
TABLE 273 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252.
TABLE 274 CORBION: PRODUCT LAUNCHES AND ENHANCEMENTS 253.
TABLE 275 CORBION: OTHER DEVELOPMENTS 253.
TABLE 276 KD PHARMA GROUP SA: COMPANY OVERVIEW 254.
TABLE 277 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 255.
TABLE 278 KD PHARMA GROUP SA: DEALS 257.
TABLE 279 KD PHARMA GROUP SA: EXPANSIONS 257.
TABLE 280 AKER BIOMARINE: COMPANY OVERVIEW 259.
TABLE 281 AKER BIOMARINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 260.
TABLE 282 AKER BIOMARINE: PRODUCT LAUNCHES AND ENHANCEMENTS 261.
TABLE 283 AKER BIOMARINE: EXPANSIONS 262.
TABLE 284 AKER BIOMARINE: DEALS 262.
TABLE 285 AKER BIOMARINE: OTHER DEVELOPMENTS 265.
TABLE 286 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW 266.
TABLE 287 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 267.
TABLE 288 EVONIK INDUSTRIES AG: COMPANY OVERVIEW 269.
TABLE 289 EVONIK INDUSTRIES AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 270.
TABLE 290 EVONIK INDUSTRIES AG: DEALS 271.
TABLE 291 PELAGIA: COMPANY OVERVIEW 273.
TABLE 292 PELAGIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 274.
TABLE 293 PELAGIA: PRODUCT LAUNCHES AND ENHANCEMENTS 275.
TABLE 294 PELAGIA AS: OTHER DEVELOPMENTS 275.
TABLE 295 GC RIEBER: COMPANY OVERVIEW 277.
TABLE 296 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 278.
TABLE 297 GC RIEBER: PRODUCT LAUNCHES AND ENHANCEMENTS 279.
TABLE 298 GC RIEBER: EXPANSIONS 279.
TABLE 299 COOKE AQUACULTURE INC.: COMPANY OVERVIEW 281.
TABLE 300 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281.
TABLE 301 COOKE AQUACULTURE INC.: DEALS 283.
TABLE 302 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW 284.
TABLE 303 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 284.
TABLE 304 ALGISYS BIOSCIENCES, INC.: OTHER DEVELOPMENTS 285.
TABLE 305 POLARIS: COMPANY OVERVIEW 286.
TABLE 306 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 286.
TABLE 307 POLARIS: PRODUCT LAUNCHES AND ENHANCEMENTS 287.
TABLE 308 POLARIS: OTHER DEVELOPMENTS 287.
TABLE 309 BTSA: COMPANY OVERVIEW 288.
TABLE 310 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 288.
TABLE 311 NOVOSANA EUROPE B.V.: COMPANY OVERVIEW 290.
TABLE 312 NOVOSANA EUROPE B.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 290.
TABLE 313 GOLDEN OMEGA: COMPANY OVERVIEW 292.
TABLE 314 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 292.
TABLE 315 GOLDEN OMEGA: DEALS 293.
TABLE 316 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW 294.
TABLE 317 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 294.
TABLE 318 RIMFROST AS: COMPANY OVERVIEW 296.
TABLE 319 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 296.
TABLE 320 RIMFROST AS: DEALS 297.
TABLE 321 MARKETS ADJACENT TO OMEGA-3 MARKET 311.
TABLE 322 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE,.
2019–2023 (USD MILLION) 312.
TABLE 323 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE,.
2024–2029 (USD MILLION) 312.
TABLE 324 MARINE COLLAGEN MARKET, BY FORM, 2022–2025 (USD MILLION) 313.
TABLE 325 MARINE COLLAGEN MARKET, BY FORM, 2026–2031 (USD MILLION) 314.